These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11886464)

  • 1. Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients.
    Royal S; Schramm W; Berntorp E; Giangrande P; Gringeri A; Ludlam C; Kroner B; Szucs T;
    Haemophilia; 2002 Jan; 8(1):44-50. PubMed ID: 11886464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes and resource utilization associated with haemophilia care in Europe.
    Schramm W; Royal S; Kroner B; Berntorp E; Giangrande P; Ludlam C; Gringeri A; Berger K; Szucs T;
    Haemophilia; 2002 Jan; 8(1):33-43. PubMed ID: 11886463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilia A management in Victorian, New South Wales and South Australian haemophilia centres.
    Ekert H; Ekert NL; Street AM; Rickard KA; McPherson VJ; Toogood IR; Lloyd JV
    Med J Aust; 1995 Jun; 162(11):569-71. PubMed ID: 7791641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-standing prophylactic therapy vs. episodic treatment in young people with severe haemophilia: a comparison of age-matched Danish and Russian patients.
    Ingerslev J; Lethagen S; Hvitfeldt Poulsen L; Sørensen B; Lopatina E; Tentsova I; Yastrubinetskaya O; Plyushch OP
    Haemophilia; 2014 Jan; 20(1):58-64. PubMed ID: 24354479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes of 182 adults with severe haemophilia in Germany comparing prophylactic vs. on-demand replacement therapy.
    Mondorf W; Kalnins W; Klamroth R
    Haemophilia; 2013 Jul; 19(4):558-63. PubMed ID: 23560639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study.
    Tagliaferri A; Feola G; Molinari AC; Santoro C; Rivolta GF; Cultrera DB; Gagliano F; Zanon E; Mancuso ME; Valdré L; Mameli L; Amoresano S; Mathew P; Coppola A;
    Thromb Haemost; 2015 Jul; 114(1):35-45. PubMed ID: 25855376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [French guidelines. Long-term prophylaxis for severe haemophilia A and B children to prevent haemophiliac arthropathy].
    Meunier S; Trossaërt M; Berger C; Borel-Derlon A; Dirat G; Donadel-Claeyssens S; Assolant AD; Guérois C; Lutz P; Rafowicz A; Rothschild C; Chambost H;
    Arch Pediatr; 2009 Dec; 16(12):1571-8. PubMed ID: 19960603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of haemophilia treatment: a cross-national assessment.
    Lippert B; Berger K; Berntorp E; Giangrande P; van den Berg M; Schramm W; Siebert U;
    Blood Coagul Fibrinolysis; 2005 Oct; 16(7):477-85. PubMed ID: 16175006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy.
    Castaman G; Rocino A; Mazzucconi MG; Zanon E; Gagliano F; Molinari AC
    Blood Transfus; 2015 Oct; 13(4):631-8. PubMed ID: 26057481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of prophylactic replacement therapy in children and adults with haemophilia.
    Ljung R; Gretenkort Andersson N
    Br J Haematol; 2015 Jun; 169(6):777-86. PubMed ID: 25819695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between prophylaxis and on demand treatment for severe haemophilia.
    Khoriaty R; Taher A; Inati A; Lee C
    Clin Lab Haematol; 2005 Oct; 27(5):320-3. PubMed ID: 16178913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres.
    Morfini M; Auerswald G; Kobelt RA; Rivolta GF; Rodriguez-Martorell J; Scaraggi FA; Altisent C; Blatny J; Borel-Derlon A; Rossi V
    Haemophilia; 2007 Sep; 13(5):502-7. PubMed ID: 17880436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Describing the quality of life of boys with haemophilia in China: Results of a multicentre study using the CHO-KLAT.
    Tang L; Xu W; Li CG; Hou F; Feng XQ; Wang H; Li XJ; Li WL; Liu JP; Sun LR; Wang SH; Jin J; Fang Q; Luke KH; Poon MC; Blanchette VS; Usuba K; Young NL; Wu R
    Haemophilia; 2018 Jan; 24(1):113-119. PubMed ID: 28922525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
    Taki M; Shirahata A
    Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.
    Berntorp E
    Haemophilia; 2009 Nov; 15(6):1219-27. PubMed ID: 19659939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between reported medication adherence and health-related quality of life in adult patients with haemophilia.
    Bago M; Butkovic A; Preloznik Zupan I; Faganel Kotnik B; Prga I; Bacic Vrca V; Zupancic Salek S
    Int J Clin Pharm; 2021 Dec; 43(6):1500-1507. PubMed ID: 33928481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort.
    Feldman BM; Rivard GE; Babyn P; Wu JKM; Steele M; Poon MC; Card RT; Israels SJ; Laferriere N; Gill K; Chan AK; Carcao M; Klaassen RJ; Cloutier S; Price VE; Dover S; Blanchette VS
    Lancet Haematol; 2018 Jun; 5(6):e252-e260. PubMed ID: 29731369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.
    Gringeri A; Leissinger C; Cortesi PA; Jo H; Fusco F; Riva S; Antmen B; Berntorp E; Biasoli C; Carpenter S; Kavakli K; Morfini M; Négrier C; Rocino A; Schramm W; Windyga J; Zülfikar B; Mantovani LG
    Haemophilia; 2013 Sep; 19(5):736-43. PubMed ID: 23731246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary prophylaxis vs. on-demand treatment to improve quality of life in severe adult haemophilia A patients: a prospective study in a single centre.
    Aznar JA; García-Dasí M; Pérez-Alenda S; Marco A; Jaca M; Moret A; Querol F
    Vox Sang; 2014 Jan; 106(1):68-74. PubMed ID: 23802855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of severe haemophilia A on patients' health status: results from the guardian(™) 1 clinical trial of turoctocog alfa (NovoEight(®) ).
    Ozelo M; Chowdary P; Regnault A; Busk AK
    Haemophilia; 2015 Jul; 21(4):451-7. PubMed ID: 25677761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.